Outside of its pain-relieving outcomes, conolidine has demonstrated a positive basic safety margin in preclinical toxicology assessments. As opposed to opioids, which often induce respiratory depression at higher doses, conolidine has not made indications of important respiratory suppression. Additionally, behavioral assessments in murine models advise an absence of drug-looking https://frankf284aqh9.yourkwikimage.com/user